GEMMABio is on a mission to develop novel gene therapies for rare diseases and provide access to patients around the world.
Our experts have played a pivotal role in the field of genetic medicines for decades, spearheading advancements in AAV-based therapies within academic and commercial settings. Founded and led by Dr. James M. Wilson, a gene therapy pioneer for over 40 years, GEMMABio builds upon his team’s unparalleled legacy of scientific excellence and innovation with global impact.
Based in Philadelphia, GEMMABio partners with domestic and international entities as it develops the next generation of advanced therapies and delivers them to those in need. The team at GEMMABio are committed to accelerating discoveries to the clinic.
